152 related articles for article (PubMed ID: 31692672)
21. Atorvastatin Prevents Early Oxidative Events and Modulates Inflammatory Mediators in the Striatum Following Intranasal 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Administration in Rats.
Marques NF; Castro AA; Mancini G; Rocha FL; Santos ARS; Prediger RD; De Bem AF; Tasca CI
Neurotox Res; 2018 Apr; 33(3):549-559. PubMed ID: 29164519
[TBL] [Abstract][Full Text] [Related]
22. Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity.
Ness GC; Chambers CM; Lopez D
J Lipid Res; 1998 Jan; 39(1):75-84. PubMed ID: 9469588
[TBL] [Abstract][Full Text] [Related]
23. Association of cholesteryl ester transfer protein mass with peripheral leukocyte count following statin therapy: a pilot study.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2012 Oct; 12(5):349-54. PubMed ID: 22900989
[TBL] [Abstract][Full Text] [Related]
24. Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin.
Bergstrom JD; Bostedor RG; Rew DJ; Geissler WM; Wright SD; Chao YS
Biochim Biophys Acta; 1998 Jan; 1389(3):213-21. PubMed ID: 9512650
[TBL] [Abstract][Full Text] [Related]
25. 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension.
Satoh M; Satoh A
J Pharm Pharm Sci; 2009 Feb; 11(2):118s-130s. PubMed ID: 19203474
[TBL] [Abstract][Full Text] [Related]
26. Automated enzyme inhibition assay method for the determination of atorvastatin-derived HMG-CoA reductase inhibitors in human plasma using radioactivity detection.
Valesky RJ; Liu L; Musson DG; Zhao JJ
J Pharmacol Toxicol Methods; 2008; 57(1):61-9. PubMed ID: 17651990
[TBL] [Abstract][Full Text] [Related]
27. [
Clemente GS; Rickmeier J; Antunes IF; Zarganes-Tzitzikas T; Dömling A; Ritter T; Elsinga PH
EJNMMI Res; 2020 Apr; 10(1):34. PubMed ID: 32296962
[TBL] [Abstract][Full Text] [Related]
28. Atorvastatin improves Y-maze learning behaviour in nicotine treated male albino rats.
Das S S; Nair SS; Kavitha S; Febi J; Indira M
Pharmacol Biochem Behav; 2015 Nov; 138():117-22. PubMed ID: 26409179
[TBL] [Abstract][Full Text] [Related]
29. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
[TBL] [Abstract][Full Text] [Related]
30. Effect of vitamin D3 derivatives on cholesterol synthesis and HMG-CoA reductase activity in cultured cells.
Gupta AK; Sexton RC; Rudney H
J Lipid Res; 1989 Mar; 30(3):379-86. PubMed ID: 2542424
[TBL] [Abstract][Full Text] [Related]
31. Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats.
Li WM; Liu W; Gao C; Zhou BG
Immunol Cell Biol; 2006 Jun; 84(3):274-80. PubMed ID: 16509827
[TBL] [Abstract][Full Text] [Related]
32. Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin.
Naoumova RP; Dunn S; Rallidis L; Abu-Muhana O; Neuwirth C; Rendell NB; Taylor GW; Thompson GR
J Lipid Res; 1997 Jul; 38(7):1496-500. PubMed ID: 9254075
[TBL] [Abstract][Full Text] [Related]
33. HMG-CoA reductase inhibitors do not improve glucose intolerance in spontaneously diabetic Goto-Kakizaki rats.
Satoh K; Keimatsu N; Kanda M; Kasai T; Takaguri A; Sun F; Ichihara K
Biol Pharm Bull; 2005 Nov; 28(11):2092-5. PubMed ID: 16272695
[TBL] [Abstract][Full Text] [Related]
34. Different cardiometabolic effects of atorvastatin in men with normal vitamin D status and vitamin D insufficiency.
Krysiak R; Gilowska M; Okopień B
Clin Cardiol; 2016 Dec; 39(12):715-720. PubMed ID: 27717074
[TBL] [Abstract][Full Text] [Related]
35. Opposite effects of pravastatin and atorvastatin on insulin sensitivity in the rat: role of vitamin D metabolites.
Bełtowski J; Atanassova P; Chaldakov GN; Jamroz-Wiśniewska A; Kula W; Rusek M
Atherosclerosis; 2011 Dec; 219(2):526-31. PubMed ID: 21889144
[TBL] [Abstract][Full Text] [Related]
36. Regression of poloxamer 407-induced atherosclerotic lesions in C57BL/6 mice using atorvastatin.
Johnston TP; Baker JC; Hall D; Jamal S; Palmer WK; Emeson EE
Atherosclerosis; 2000 Apr; 149(2):303-13. PubMed ID: 10729380
[TBL] [Abstract][Full Text] [Related]
37. Consortia of bioactives in supercritical carbon dioxide extracts of mustard and small cardamom seeds lower serum cholesterol levels in rats: new leads for hypocholesterolaemic supplements from spices.
Chakraborty S; Paul K; Mallick P; Pradhan S; Das K; Chakrabarti S; Nandi DK; Bhattacharjee P
J Nutr Sci; 2019; 8():e32. PubMed ID: 31595188
[TBL] [Abstract][Full Text] [Related]
38. The eye lens evaluation of the atorvastatin-treated white rat.
Zakrzewski P; Milewska J; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):165-71. PubMed ID: 12898835
[TBL] [Abstract][Full Text] [Related]
39. Fertility and general reproduction studies in rats with the HMG-CoA reductase inhibitor, atorvastatin.
Dostal LA; Whitfield LR; Anderson JA
Fundam Appl Toxicol; 1996 Aug; 32(2):285-92. PubMed ID: 8921332
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin withdrawal elicits oxidative/nitrosative damage in the rat cerebral cortex.
de Oliveira CV; Funck VR; Pereira LM; Grigoletto J; Rambo LM; Ribeiro LR; Royes LF; Furian AF; Oliveira MS
Pharmacol Res; 2013 May; 71():1-8. PubMed ID: 23428346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
